Summary of Financial Indicators

Financial Indicators (TRY)2023/122024/03
Total Assets77,327,803,42287,713,201,082
Total Liabilities61,902,221,11668,668,006,182
Paid-in Capital1,161,523,3631,161,523,363
Shareholder’s Equity15,425,582,30619,045,194,900
2023/032024/03
Premium Production12,175,330,62828,162,729,848
Gross Claims Paid-3,719,764,700-6,910,713,249
Operational Expenses-811,581,722-2,069,125,992
Investment Income1,161,608,4195,572,036,759
Investment Expenses-1,154,215,928-5,352,929,900
Net Investment Income7,392,491219,106,859
Extraordinary Income Expenses-251,117,863-614,965,762
Technical Profit928,306,422
4,621,183,149
Net Profit537,027,5763,526,611,681
Ratios Regarding Asset Quality & Liquidity2023/122024/03
 Cash Ratio87%82%
 Liquidity Ratio105%108%
 Current Ratio114%119%
 Receivables from Premium and Reinsurance / Total Assets15%20%
 Asset Profitability12%17%
 Equity Profitability56%82%
Operational Ratios2023/032024/03
 Retention Ratio50%41%
 Claims Paid / (Claims Paid + Outstanding Claims)17%21%
Profitability Ratios2023/032024/03
 Net Loss/Premium Ratio73%70%
 Net Commission Ratio11%12%
 Net Expense Ratio13%9%
 Net Compound Ratio97%90%